CD8A and neoplasm: Thirdly, and although IL-15 promotes the antitumor immunity mediated by NK cells and CD8+ T cells, certain tumor-promoting properties of IL-15 and/or IL-15/IL-15Rα have been noted in patients with leukemia or solid tumors (83, 84).